AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Metgreat-G2 Tablet SR

Prescription Icon
Prescription Required

Marketer

NYG Pharmaceuticals Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Metgreat-G2 Tablet SR

Diabex Duo SR tablets are a dual-action antidiabetic medication used to manage type 2 diabetes in adults. This combination therapy helps regulate blood glucose levels. Diabex Duo SR should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial, even with controlled blood sugar or feeling well; abrupt cessation can lead to dangerously elevated glucose levels, increasing the risk of complications such as kidney failure, vision loss, neuropathy, and limb amputation. Diabex Duo SR is one component of a comprehensive diabetes management plan, incorporating a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is the most frequent side effect, manifesting as sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential to mitigate this risk. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste perception, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections; weight gain may also occur. Diabex Duo SR is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of heart disease should inform their doctor before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is necessary, and your doctor may recommend blood tests to track blood cell counts and liver function.

Uses of Metgreat-G2 Tablet SR

Managing type 2 diabetes

Major Benefits of Metgreat-G2 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Metgreat-G2 Tablet SR whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

Common Side effects of Metgreat-G2 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Metgreat-G2 Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Metgreat-G2 Tablet SR with a meal.

How Metgreat-G2 Tablet SR works:

Metformin and Glimepiride, the components of Metgreat-G2 SR tablets, offer a dual approach to diabetes management. Glimepiride, a sulfonylurea, stimulates the pancreas to produce more insulin, thus reducing blood sugar. Metformin, a biguanide, acts through a three-pronged mechanism: decreasing liver glucose output, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Metgreat-G2 Tablet SR and alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Metgreat-G2 Tablet SR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against possible risks prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingUNSAFE

Extended-release Metgreat-G2 tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Metgreat-G2 SR tablets cautiously, potentially requiring dosage modification. Consult your physician for guidance. Metgreat-G2 SR tablets are contraindicated in patients with severe kidney disease. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Metgreat-G2 Tablet SR cautiously, potentially requiring dosage modifications. Physician consultation is advised. A low initial dose is typically prescribed for those with mild to moderate liver disease; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Metgreat-G2 Tablet SR :

Should you forget a Metgreat-G2 Tablet SR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Metgreat-G2 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Metgreat-G2 Tablet SR

Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication safely and ensure it remains inaccessible to children, pets, and others.
Metgreat-G2 Tablet SR can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Metgreat-G2 Tablet SR and seek immediate medical attention.
Metgreat-G2 Tablet SR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 DM.
Metgreat-G2 Tablet SR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Metgreat-G2 Tablet SR use can lead to vitamin B12 deficiency by interfering with its absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Metgreat-G2 Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Consuming alcohol with Metgreat-G2 Tablet SR is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Metgreat-G2 Tablet SR
121
MRP 140
13% off